Accustem Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Cash & Equivalents	0.02	0.73	0	0
Cash & Cash Equivalents	0.02	0.73	0	0
Cash Growth	-97.07%	-	-	-
Receivables	0	0	1.35	1.37
Other Current Assets	0.11	0.2	0	-0
Total Current Assets	0.13	0.93	1.35	1.37
Property, Plant & Equipment	0	0.01	0	0
Long-Term Investments	0	0	0.2	0.21
Intangible Assets	0	0	0	0
Other Long-Term Assets	-0	-0	0	-0
Total Long-Term Assets	0	0.01	0.2	0.21
Total Assets	0.13	0.94	1.56	1.57
Accounts Payable	0.58	0.31	0.39	0
Current Debt	0.06	0.11	0	0
Other Current Liabilities	1.61	0.66	0.31	0.06
Total Current Liabilities	2.25	1.08	0.7	0.06
Other Long-Term Liabilities	0	0.31	0.39	0
Total Long-Term Liabilities	0	0.31	0.39	0
Total Liabilities	2.25	1.08	0.7	0.06
Total Debt	0.06	0.11	0	0
Debt Growth	-47.74%	-	-	-
Common Stock	0.01	0.01	0.01	0.01
Retained Earnings	-6.52	-4.47	-0.72	-0.05
Comprehensive Income	-0	0	0.07	0.08
Shareholders' Equity	-2.11	-0.14	0.86	1.52
Total Liabilities and Equity	0.13	0.94	1.56	1.57
Net Cash / Debt	-0.03	0.63	0	0
Net Cash Per Share	-0.00	0.06	-	0.00
Working Capital	-2.12	-0.15	0.65	1.31
Book Value Per Share	-0.19	-0.01	0.08	0.13

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.